292 related articles for article (PubMed ID: 36978921)
1. A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies.
Segura-Aguilar J; Mannervik B
Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978921
[TBL] [Abstract][Full Text] [Related]
2. Single-neuron neurodegeneration as a degenerative model for Parkinson's disease.
Huenchuguala S; Segura-Aguilar J
Neural Regen Res; 2024 Mar; 19(3):529-535. PubMed ID: 37721280
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase.
Segura-Aguilar J; Muñoz P; Inzunza J; Varshney M; Nalvarte I; Mannervik B
Antioxidants (Basel); 2022 Jan; 11(2):. PubMed ID: 35204179
[TBL] [Abstract][Full Text] [Related]
4. Protective and toxic roles of dopamine in Parkinson's disease.
Segura-Aguilar J; Paris I; Muñoz P; Ferrari E; Zecca L; Zucca FA
J Neurochem; 2014 Jun; 129(6):898-915. PubMed ID: 24548101
[TBL] [Abstract][Full Text] [Related]
5. Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease.
Paris I; Cardenas S; Lozano J; Perez-Pastene C; Graumann R; Riveros A; Caviedes P; Segura-Aguilar J
Neurotox Res; 2007 Sep; 12(2):125-34. PubMed ID: 17967736
[TBL] [Abstract][Full Text] [Related]
6. On the role of endogenous neurotoxins and neuroprotection in Parkinson's disease.
Segura-Aguilar J
Neural Regen Res; 2017 Jun; 12(6):897-901. PubMed ID: 28761417
[TBL] [Abstract][Full Text] [Related]
7. Targets to Search for New Pharmacological Treatment in Idiopathic Parkinson's Disease According to the Single-Neuron Degeneration Model.
Huenchuguala S; Segura-Aguilar J
Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927076
[TBL] [Abstract][Full Text] [Related]
8. Molecular and neurochemical mechanisms in PD pathogenesis.
Paris I; Lozano J; Perez-Pastene C; Muñoz P; Segura-Aguilar J
Neurotox Res; 2009 Oct; 16(3):271-9. PubMed ID: 19526278
[TBL] [Abstract][Full Text] [Related]
9. Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
Herrera A; Muñoz P; Steinbusch HWM; Segura-Aguilar J
ACS Chem Neurosci; 2017 Apr; 8(4):702-711. PubMed ID: 28233992
[TBL] [Abstract][Full Text] [Related]
10. DT-diaphorase protects astrocytes from aminochrome-induced toxicity.
Huenchuguala S; Muñoz P; Graumann R; Paris I; Segura-Aguilar J
Neurotoxicology; 2016 Jul; 55():10-12. PubMed ID: 27168424
[TBL] [Abstract][Full Text] [Related]
11. On the Role of DT-Diaphorase Inhibition in Aminochrome-Induced Neurotoxicity In Vivo.
Herrera-Soto A; Díaz-Veliz G; Mora S; Muñoz P; Henny P; Steinbusch HWM; Segura-Aguilar J
Neurotox Res; 2017 Jul; 32(1):134-140. PubMed ID: 28285345
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase.
Graumann R; Paris I; Martinez-Alvarado P; Rumanque P; Perez-Pastene C; Cardenas SP; Marin P; Diaz-Grez F; Caviedes R; Caviedes P; Segura-Aguilar J
Pol J Pharmacol; 2002; 54(6):573-9. PubMed ID: 12866711
[TBL] [Abstract][Full Text] [Related]
13. Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity.
Segura-Aguilar J; Mannervik B; Inzunza J; Varshney M; Nalvarte I; Muñoz P
Neural Regen Res; 2022 Sep; 17(9):1861-1866. PubMed ID: 35142659
[TBL] [Abstract][Full Text] [Related]
14. Dopamine in Parkinson's disease.
Latif S; Jahangeer M; Maknoon Razia D; Ashiq M; Ghaffar A; Akram M; El Allam A; Bouyahya A; Garipova L; Ali Shariati M; Thiruvengadam M; Azam Ansari M
Clin Chim Acta; 2021 Nov; 522():114-126. PubMed ID: 34389279
[TBL] [Abstract][Full Text] [Related]
15. To what extent may aminochrome increase the vulnerability of dopaminergic neurons in the context of Parkinson's disease.
Chagraoui A; Anouar Y; De Deurwaerdere P; Arias HR
Int J Biochem Cell Biol; 2024 Mar; 168():106528. PubMed ID: 38246261
[TBL] [Abstract][Full Text] [Related]
16. Dopamine oxidation and autophagy.
Muñoz P; Huenchuguala S; Paris I; Segura-Aguilar J
Parkinsons Dis; 2012; 2012():920953. PubMed ID: 22966478
[TBL] [Abstract][Full Text] [Related]
17. Stable expression of short interfering RNA for DT-diaphorase induces neurotoxicity.
Lozano J; Muñoz P; Nore BF; Ledoux S; Segura-Aguilar J
Chem Res Toxicol; 2010 Sep; 23(9):1492-6. PubMed ID: 20849151
[TBL] [Abstract][Full Text] [Related]
18. Aminochrome Induces Neuroinflammation and Dopaminergic Neuronal Loss: A New Preclinical Model to Find Anti-inflammatory and Neuroprotective Drugs for Parkinson's Disease.
De Araújo FM; Frota AF; de Jesus LB; Macedo TC; Cuenca-Bermejo L; Sanchez-Rodrigo C; Ferreira KMS; de Oliveira JVR; de Fatima Dias Costa M; Segura-Aguilar J; Costa SL; Herrero MT; Silva VDA
Cell Mol Neurobiol; 2023 Jan; 43(1):265-281. PubMed ID: 34988761
[TBL] [Abstract][Full Text] [Related]
19. Aminochrome as preclinical model for Parkinson's disease.
Segura-Aguilar J
Oncotarget; 2017 Jul; 8(28):45036-45037. PubMed ID: 28586763
[No Abstract] [Full Text] [Related]
20. Why are neuromelanin-containing dopaminergic neurons lost in idiopathic Parkinson's disease?
Huenchuguala S; Segura-Aguilar J
Cell Mol Life Sci; 2023 Sep; 80(10):281. PubMed ID: 37688601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
